Neurofibromatosis type 1: New developments in genetics and treatment
- 1 June 2021
- journal article
- research article
- Published by Elsevier in Journal of the American Academy of Dermatology
- Vol. 84 (6) , 1667-1676
Abstract
No abstract availableKeywords
This publication has 118 references indexed in Scilit:
- An Absence of Cutaneous Neurofibromas Associated with a 3-bp Inframe Deletion in Exon 17 of the NF1 Gene (c.2970-2972 delAAT): Evidence of a Clinically Significant NF1 Genotype-Phenotype CorrelationThe American Journal of Human Genetics, 2007
- Optic-nerve gliomas, chiasmal gliomas and neurofibromatosis type 1Current Opinion in Ophthalmology, 2006
- NF1 Gene Mutations Represent the Major Molecular Event Underlying Neurofibromatosis-Noonan SyndromeThe American Journal of Human Genetics, 2005
- Recurrent mutations in the NF1 gene are common among neurofibromatosis type 1 patientsJournal of Medical Genetics, 2003
- Review Article : Genetics of Neurofibromatosis 1 and the NF1 GeneJournal of Child Neurology, 2002
- Schwannoma (Neurilemoma) with Malignant Transformation A Rare, Distinctive Peripheral Nerve TumorAmerican Journal of Surgical Pathology, 1994
- The protein product of the neurofibromatosis type 1 gene is expressed at highest abundance in neurons, Schwann cells, and oligodendrocytesNeuron, 1992
- Watson syndrome: is it a subtype of type 1 neurofibromatosis?Journal of Medical Genetics, 1991
- Use of the Carbon Dioxide Laser in Treating Multiple Cutaneous NeurofibromasAnnals of Plastic Surgery, 1991
- Antique Illustrations of NeurofibromatosisInternational Journal of Dermatology, 1980